Con: Ambulatory blood pressure measurement in patients receiving haemodialysis: A sore arm and a waste of time?

Nephrology Dialysis Transplantation

Volumn 30, Issue 9, 2015, Pages 1438-1441

  Jardine, Alan G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ambulatory monitoring; cardiovascular risk; haemodialysis; hypertension

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT RESPONSE; DISEASE MANAGEMENT; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; DISEASE MANAGEMENT; HUMANS; HYPERTENSION; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84940662609     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv244     Document Type: Review

References (24)

1. Patel RK, Oliver S, Mark PB et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol 2009; 4: 1477-1483
2. Stewart GA, Gansevoort RT, Mark PB et al. Electrocardiographic abnormalities and uraemic cardiomyopathy. Kidney Int 2005; 67: 217-226
3. Stewart GA, Mark P, Johnstone N et al. Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 2004; 24: 387-393
4. Mancia G, VerDecchia P. Clinical value of ambulatory blood pressure: eviDence and limits. Circ Res 2015; 116: 1034-1045
5. Niiranen TJ, Mäki J, Puukka P et al. Office, home, and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension 2014; 64: 281-286
6. Minutolo R, Gabbai FB, Agarwal R et al. Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicentre prospective cohort study. Am J Kidney Dis 2014; 64: 744-752
7. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152
8. Foley RN, Parfrey PS, Harnett JD et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-1385
9. Foley RN, Parfrey PS, Harnett JD et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. JAmSoc Nephrol 1995; 5: 2024-2031
10. SchneiDer A, Jardine AG, SchneiDer MP et al. Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study. Am J Nephrol 2013; 37: 144-151
11. Mark PB, Johnston N, Groenning BA et al. ReDefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006; 69: 1839-1845
12. Zager PG, Nikolic J, Brown RH et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998; 54: 561-569
13. Agarwal R. Home and ambulatory blood pressure monitoring in chronic kidney disease. Curr Opin Nephrol Hypertens 2009; 18: 507-512
14. Thomson AM, Pickering TG. The role of Ambulatory Blood Pressure monitoring in chronic and end stage kidney disease. Kidney Int 2006; 76: 1000-1007
15. Liu M, Takahashi H, Morita Y et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 563-569
16. Amal J, Vernier I, Rossignol E et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 2000; 57: 2485-2491
17. Tripepi G, Fagugli RM, Dattolo P et al. Prognostic value of 24-hour ambulatory blood pressuremonitoring and of night/Day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int 2005; 68: 1294-1302
18. Conlon PJ, Walshe JJ, Heinle SK et al. Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and LV mass in stable hemodialysis patients. J AmSoc Nephrol 1996; 7: 2658-2663
19. Zoccali C, Mallamaci F, Tripepi G et al. Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients. J Hypertens 1999; 17: 1751-1758
20. Wheeler DC, Becker GJ. Summary of KDIGO guiDeline. What do we really know about management of blood pressure in patients with chronic kidney disease Kidney Int 2013; 83: 377-383
21. Zocalli C. Traditional and emerging cardiovascular and renal risk factors: an epiDemiologic perspective. Kidney Int 2006; 70: 26-33
22. Zocalli C, Torino C, Tripepi R et al. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol 2013; 24: 1-8
23. Velasco N, Chamney P,Wabel P et al. Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients. Hemodial Int 2012; 16: 465-472
24. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291-1299